Thomas J. Wilson
No más puestos en curso
Perfil
Mr. Thomas J.
Wilson is Vice President-Quality Assurance at Synta Pharmaceuticals Corp.
Mr. Wilson was previously employed as a Director-Quality & Analytical by Euthymics Bioscience, Inc., a Principal by Granutec, Inc., and a Principal by Mallinckrodt Animal Health, Inc.
He received his undergraduate degree from Truman State University and a graduate degree from Kansas State University.
Antiguos cargos conocidos de Thomas J. Wilson.
Empresas | Cargo | Fin |
---|---|---|
Euthymics Bioscience, Inc.
Euthymics Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Euthymics Bioscience, Inc. develops a novel medicine for alcohol use disorder (AUD) and smoking cessation. It engages in developing a medicine for central nervous system disorders of significant unmet medical need, including major depressive disorder (MDD) and alcohol use disorder (AUD). The firm provides Amitifadine, an antidepressant for major depressive disorder. The firm focuses on the modulation of neurotransmitters, including serotonin (5-HT), norepinephrine (NE), and dopamine (DA). The company was founded by Anthony A. McKinney and Franklin P. Bymaster in 2009 and is headquartered in Cambridge, MA. | Director Técnico/Científico/I+D | 06/06/2011 |
Synta Pharmaceuticals Corp.
Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Synta Pharmaceuticals Corp. discovers, develops and commercializes pharmaceutical products. It focuses on the research, development and commercialization of oncology medicines that provides treatment to cancer patients. The company is also developing a proprietary platform for delivery of anti-cancer drugs directly to tumor cells, known as Hsp90-inhibitor drug conjugates. Synta Pharmaceuticals was founded by Safi R. Bahcall and Lan-Bo Chen in March 2000 and is headquartered in Lexington, MA. | Corporate Officer/Principal | - |
Granutec LLC
Granutec LLC Industrial MachineryProducer Manufacturing Granutec LLC manufactures granulator machines and auxiliary equipment. The firm’s granulators include auger-matic granulators, tangential feed and central granulators. It offers a selection of in-house designed and manufactured auxiliary machines, including heavy duty blowers and cyclones, and metal detector systems. The company was founded by Merritt Tetreault in 1980 and is headquartered in Rockville, MD. | Corporate Officer/Principal | - |
Mallinckrodt Animal Health, Inc. | Corporate Officer/Principal | - |
Formación de Thomas J. Wilson.
Kansas State University | Graduate Degree |
Truman State University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 4 |
---|---|
Synta Pharmaceuticals Corp.
Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Synta Pharmaceuticals Corp. discovers, develops and commercializes pharmaceutical products. It focuses on the research, development and commercialization of oncology medicines that provides treatment to cancer patients. The company is also developing a proprietary platform for delivery of anti-cancer drugs directly to tumor cells, known as Hsp90-inhibitor drug conjugates. Synta Pharmaceuticals was founded by Safi R. Bahcall and Lan-Bo Chen in March 2000 and is headquartered in Lexington, MA. | Health Technology |
Granutec LLC
Granutec LLC Industrial MachineryProducer Manufacturing Granutec LLC manufactures granulator machines and auxiliary equipment. The firm’s granulators include auger-matic granulators, tangential feed and central granulators. It offers a selection of in-house designed and manufactured auxiliary machines, including heavy duty blowers and cyclones, and metal detector systems. The company was founded by Merritt Tetreault in 1980 and is headquartered in Rockville, MD. | Producer Manufacturing |
Euthymics Bioscience, Inc.
Euthymics Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Euthymics Bioscience, Inc. develops a novel medicine for alcohol use disorder (AUD) and smoking cessation. It engages in developing a medicine for central nervous system disorders of significant unmet medical need, including major depressive disorder (MDD) and alcohol use disorder (AUD). The firm provides Amitifadine, an antidepressant for major depressive disorder. The firm focuses on the modulation of neurotransmitters, including serotonin (5-HT), norepinephrine (NE), and dopamine (DA). The company was founded by Anthony A. McKinney and Franklin P. Bymaster in 2009 and is headquartered in Cambridge, MA. | Commercial Services |
Mallinckrodt Animal Health, Inc. |
- Bolsa de valores
- Insiders
- Thomas J. Wilson